Table 6.
THA | HA | P-value | Mean Difference (95% CI) | |
---|---|---|---|---|
Overall | 74 (44%) | 94 (56%) | ||
Gender | P = .18a | |||
Male | 26 (35.1%) | 24 (25.5%) | ||
Female | 48 (64.9%) | 70 (74.5%) | ||
Age | 72.0 (7.0) | 77.7 (8.6) | P = .00b | −5.76 (−8.18, −3.35) |
Age group | P = .00a | |||
60-69 years | 27 (60.0%) | 18 (40.0%) | ||
70-79 years | 35 (53.8%) | 30 (46.2%) | ||
80-89 years | 12 (23.5%) | 39 (76.5%) | ||
90-99 years | 0 (.0%) | 7 (100.0%) | ||
ASA status | P = .21a | |||
1 | 10 (58.8%) | 7 (41.2%) | ||
2 | 38 (38.4%) | 61 (61.6%) | ||
3 | 26 (50.0%) | 26 (50.0%) | ||
Fracture presentation | P = .08a | |||
Acute | 63 (85.1%) | 87 (92.6%) | ||
Chronic | 11 (14.9%) | 7 (7.4%) | ||
Mode of anaesthesia | P = .00a | |||
General anaesthesia | 64 (86.5%) | 48 (51.1%) | ||
Regional anaesthesia | 10 (13.5%) | 46 (48.9%) | ||
Non-hip complications | P = .13c | |||
None | 54 (73.0%) | 56 (59.6%) | ||
1 | 18 (24.3%) | 28 (29.8%) | ||
2 or more | 2 (2.7%) | 10 (10.6%) | ||
Hip complications | P = 1.00a | |||
None | 69 (93.2%) | 88 (93.6%) | ||
1 or more | 5 (6.8%) | 6 (6.4%) | ||
Time to surgery (days) | 20.3 (1.4) | 19.5 (1.3) | P = .00b | .79 (.34, 1.24) |
Length of stay (days) | 18.4 (9.4) | 15.8 (8.2) | P = .09b | 2.57 (−.14, 5.55) |
Duration of surgery (mins) | 137.3 (20.9) | 99.3 (26.5) | P = .00b | 37.97 (29.78, 46.16) |
EBL (ml) | 575.6 (229.9) | 451.1 (224.2) | P = .02b | 124.48 (14.93, 234.02) |
WOMAC physical function | 9.1 (13.8) | 13.8 (12.9) | P = .09b | −4.66 (−10.08, .76) |
Values for age, time to surgery, length of stay, duration of surgery and EBL are presented as mean (SD). Chronic fractures are defined as those that presented after 3 weeks. ASA: American Society of Anesthesiologists. THA: total hip arthroplasty. HA: hemiarthroplasty. EBL: Estimated blood loss.
aP-value determined by Pearson’s chi-square test.
bP-value determined by independent samples t-test.
cP-value determined by Fisher’s exact test.